Everything Clinical Trials
Designing studies, capturing and monitoring trial data, managing investigator sites and everything in between.
The what, the why and the how of a holistic, quality-based approach to monitoring
In this two-part blog, we’ll first explore the technology roadmap to RBM we outlined and discussed, and next week we’ll bring you some key themes addressing practical considerations in adopting an RBM approach in your next clinical study.
The stakes for delays in clinical research are high.
Digital transformation: this is one of the hottest topics in our industry today, creating both opportunities and challenges for our customers. For pharmaceutical, biotech, and medical device companies, the promise of making data-driven, insights-led decisions in real-time means getting the right treatments to the right patients at the right time. To truly realize this potential, they need to rely on combined insights from both clinical and commercial data.
So far Edge Trial Assurance has been used in 30 trials. It has detected 50-75 data anomalies in every single trial.